Femasys secured FDA approval to proceed with the final phase of its pivotal FemBloc trial, a key step toward U.S. market ...

AstraZeneca shareholders approved a direct listing of the drugmaker's shares on the New York Stock Exchange on Monday, giving it access to a deeper capital pool.

UnitedHealth's Q3 earnings surpassed expectations, breaking a missing streak and signaling a potential operational turnaround ...

The Company signed with three B2B partners and received non-refundable deposits and non-binding preorders from them totaling more than 200 units ...

Each Halloween, poison centers in the United States see a spike in the number of calls about glow products such as glow ...

Welcome to November, star seeds. As we move deeper into the dark half of the year, our march towards night will not be gentle ...

Growth has accelerated in the second half of the year -- and 2026 looks promising, too. In short, the company's latest update points to a return to a more normal growth cadence in 2026. And based on ...

Mark Zuckerberg's Meta is spending untold billions on infrastructure and top talent for its AI ambitions. Investors are rattled.

Head over to Amazon to get the Shark Air Purifier for just $160, down from its usual price of $250. That’s a discount of $90 ...

Flowserve shows renewed growth with a rising backlog, asbestos resolution, and strong 22% return potential. Learn why FLS ...

OpenAI is preparing for a $1 trillion IPO that could launch in 2026. The ChatGPT maker plans to raise at least $60 billion ...

While you can get the white Elite Series 2 controller for the cheaper price of just $130, that only comes with the core controller plus a tool for thumbstick adjustment and a USB-C cable. The Xbox ...